News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dowpharma (DOW) Selects Mentus As Agency Of Record


10/19/2005 5:12:29 PM

SAN DIEGO, Sept. 21 /PRNewswire/ -- Mentus Life Science, a San Diego based fully integrated marketing communications agency, today announced that it has been selected by Dowpharma(SM) contract manufacturing services, a business unit of The Dow Chemical Company located in San Diego, to provide strategic public relations and marketing communications services for its biopharmaceutical platform. As Dowpharma's agency of record, Mentus will develop and execute a comprehensive marketing campaign, including media relations, product launch activities, media planning, collateral development and advertising for Dowpharma's biopharmaceutical platform which includes it's Pfenex Expression Technology, PEGylation, vaccines and other technology offerings.

"We appreciate the confidence that Dowpharma has placed in our agency to further develop it's business unit and technology offerings," said Joleen Schultz, Principal and National Practice Leader, Life Science for Mentus. "Our relationship with Dow reflects the optimum utilization of our integrated services, including strategic counsel, public relations and collateral and advertising development."

"Mentus' intimate knowledge of life sciences will be invaluable as we continue the successful marketing of our Pfenex Expression Technology and expand our other offerings," said Kathleen Davis, Business Communications Leader for Dowpharma. "With 25 years of experience in the field of biotechnology, Mentus understands our audiences and objectives, and will implement strategic initiatives, therein gaining Dowpharma both market exposure and visibility."

Pfenex is a Pseudomonas- based expression technology, designed to deliver high peptide yields, cost effectively. Pfenex accelerates speed to market by surpassing the quality and yield capabilities of existing microbial expression systems. The improved yields translate into lower cost of goods, while strain optimization helps to eliminate production problems early and avoid costly delays on the back end. This technology can be combined with other Dowpharma technologies, such as PEGylation, to positively impact a product's bottom line.

About Dowpharma Contract Manufacturing Services

Dowpharma contract manufacturing services is focused on becoming a process development partner with its customers, providing control and flexibility in enhancing the expression and production of therapeutics. Dowpharma has the infrastructure to handle the rapid and linear scale-up of process development programs. Its San Diego site consists of four facilities housing commercial, project management and operational staff, as well as researchers and scientists working and operating in microbiology laboratories and small- and medium-scale pilot plants.

About Dowpharma(SM)

Dowpharma(SM) serves the pharmaceutical and biopharmaceutical industries with innovative technologies, products, and services in drug discovery, development, delivery and manufacturing. With over three decades of experience, Dowpharma combines the resources and capabilities of several offerings to create a single-market-focused organization with broad service and support capabilities for large and emerging pharmaceutical companies. For more information on Dowpharma, visit www.dowpharma.com

About Mentus Life Science

With over a quarter century of experience, Mentus Life Science is a leading integrated marketing communications firm specializing in the life sciences industries, including medical device and diagnostics, biotechnology, pharmaceuticals and consumer healthcare. Headquartered in San Diego, the firm serves clients throughout the U.S. and globally ranging from start-up companies to the Fortune 500. For more information, visit www.mentus.com.

Mentus Life Science

CONTACT: Kathy Witz Sweeney, ext. 230, kwitz@mentus.com or Megan SwanlandRiggs, ext. 200, megan@mentus.com, both of Mentus, +1-858-455-5500


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES